Evidence map›Paper›PMID 35166769›Full record

ArticleRheumatology (Oxford, England)2022

Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis: reply.

Idil Esen, William F Jiemy, Yannick van Sleen, Rosanne D Reitsema, Johan Bijzet, Daniel M de Jong, Pieter H Nienhuis, Riemer H J A Slart, Peter Heeringa, Annemieke M H Boots and 1 more

Open access · hybridAbstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Rheumatology (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Idil EsenDepartment of Rheumatology and Clinical Immunology.ORCID 0000-0002-2054-6209
William F JiemyDepartment of Rheumatology and Clinical Immunology.
Yannick van SleenDepartment of Rheumatology and Clinical Immunology.ORCID 0000-0002-7382-8322
Rosanne D ReitsemaDepartment of Rheumatology and Clinical Immunology.ORCID 0000-0002-4250-0930
Johan BijzetDepartment of Rheumatology and Clinical Immunology.
Daniel M de JongDepartment of Rheumatology and Clinical Immunology.
Pieter H NienhuisDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen.
Riemer H J A SlartDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen.ORCID 0000-0002-5565-1164
Peter HeeringaDepartment of Pathology and Medical Biology, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-8684-763X
Annemieke M H BootsDepartment of Rheumatology and Clinical Immunology.
Elisabeth BrouwerDepartment of Rheumatology and Clinical Immunology.
University Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Giant Cell ArteritisBiomarkersHumansInflammationPyruvate KinaseBiomarkersPyruvate Kinase

Identifiers

PMID35166769
PMCPMC9258531
OpenAlexW4210840302

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.